tiprankstipranks
Ionis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
PremiumThe FlyIonis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
18d ago
Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives
Premium
Ratings
Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives
1M ago
Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James
1M ago
Ionis Pharmaceuticals price target lowered to $64 from $67 at Citi
PremiumThe FlyIonis Pharmaceuticals price target lowered to $64 from $67 at Citi
1M ago
Ionis Pharmaceuticals Reports Strong 2024 Results
Premium
Company Announcements
Ionis Pharmaceuticals Reports Strong 2024 Results
1M ago
Ionis Pharmaceuticals: Positive Sentiment in Earnings Call
Premium
Company Announcements
Ionis Pharmaceuticals: Positive Sentiment in Earnings Call
1M ago
Ionis Pharmaceuticals trading halted, volatility trading pause
PremiumThe FlyIonis Pharmaceuticals trading halted, volatility trading pause
1M ago
Morning Movers: SolarEdge skyrockets following fourth quarter earnings
Premium
The Fly
Morning Movers: SolarEdge skyrockets following fourth quarter earnings
1M ago
Ionis Pharmaceuticals sees FY25 revenue $600M, consensus $677.05M
Premium
The Fly
Ionis Pharmaceuticals sees FY25 revenue $600M, consensus $677.05M
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100